Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of January 3, 2025 • 5:31 PM ET

Date/Time Source News Release
12/18/2024 08:00 PM EST Newsfile InMed Announces Results of 2024 Annual General Meeting
12/17/2024 04:56 PM EST Newsfile InMed Enters Into Standby Equity Purchase Agreement
11/19/2024 07:30 AM EST Newsfile InMed Announces Publication of Study on Anti-Inflammation by Modulation of Endocannabinoid System
11/14/2024 04:45 PM EST Newsfile InMed Reports First Quarter Fiscal 2025 Financial Results and Provides Business Update
11/08/2024 04:44 PM EST Newsfile InMed Announces Share Consolidation to Satisfy Nasdaq Listing Rules
11/05/2024 08:30 AM EST Newsfile InMed Pharmaceuticals Announces Decision by NASDAQ Hearings Panel to Grant Exception to Implement Share Consolidation to Satisfy NASDAQ Listing Rules
10/28/2024 07:30 AM EDT Newsfile InMed Pharmaceuticals Files Additional Patent Application for INM-901 in the Treatment of Neurodegenerative Conditions Including Alzheimer's Disease
10/24/2024 08:00 AM EDT Newsfile InMed to Participate in Fierce Biotech Webinar on Neuroinflammation in Alzheimer's Disease
10/22/2024 08:00 AM EDT Newsfile InMed Appoints Dr. Barry Greenberg, Johns Hopkins University School of Medicine, to its Scientific Advisory Board
09/30/2024 08:00 AM EDT Newsfile InMed Pharmaceuticals Reports Full Year Fiscal 2024 Financial Results and Provides Business Update
Page